Specialties

Olmesartan reduced the risk of microalbuminuria by 23% in normoalbuminuric patients with Type 2 diabetes and at least one additional cardiovascular disease risk factor, results from a large European trial showed.

Long-term fenofibrate use may protect against the loss of underlying renal function in patients with Type 2 diabetes, according to late-breaking trial results just released.

French study suggesting delayed progression gets guarded response from U.S. experts.

A small study found that more than half of patients with psoriasis met diagnostic criteria for metabolic syndrome.

Gastric electrical stimulation is a reasonable alternative to insulin and oral hypoglycemic agents in obese Type 2 diabetics who are poorly controlled by oral agents and who are not candidates for gastric bypass surgery.

European organizations are calling for improved care and screening for CVD and diabetes in those with mental illnesses.

For men with Type 2 diabetes, the eosinophil (a cell type linked to allergic inflammation) cell count may be able to estimate the risk of diabetes-related kidney and heart disease in men. This comes from a recently published study in Japan.

Waist-to-hip circumference ratio (WHR) may be a better predictor of all-cause mortality in older adults versus body mass index (BMI), according to the results of a study.

There are common genetic factors that slightly predispose individuals to develop both periodontal disease and cardiovascular disease, a prospective study of Swedish twins indicates.

Interview with Ralph L. Sacco, MD. Strokes are increasing in our diabetes patients as they age and tPA has been the standard of care in the emergency room, but within 3 hours or forget it. Now news from a new consensus from the American Heart Association (AHA)/American Stroke Association (ASA) …